Seattle, WA -- (SBWire) -- 10/03/2019 --Biomarker or biological marker is a measurable indicator for some biological condition or state. It is evaluated to examine biological processes, pharmacologic responses, and pathogenic processes to therapeutic interventions and used in several scientific fields. Biomarkers can be any molecules such as DNA (genes), proteins or hormones that indicate about the health and can be classified on basis of different parameters including imaging biomarkers or molecular biomarkers. Since, the use of biomarkers decreases cost, increases success rate in drug development process, and improves patient outcome; the demand for biomarkers for drug discovery is expected to increase.
Moreover, biomarkers are also used in predicting drug efficacy more quickly than other traditional methods. Biomarkers are gaining significant popularity in product development and treatment of disease related to chromosome structure, Turner syndrome, Down syndrome, Patau syndrome, Edwards's syndrome, and others, which is boosting the demand for biomarkers. For instance, in February 2018, the U.S. Food and Drug Administration (FDA) granted marketing authorization to Banyan Biomarkers, Inc. for the first diagnostic blood test for traumatic brain injury, Banyan BTI. Thus, increasing launch of such novel diagnostic tools for various disease indications is expected to boost the global biomarkers market growth during the forecast period.
Request Sample Copy of This Report - https://www.coherentmarketinsights.com/insight/request-sample/1530
Moreover, pharmaceutical companies around the globe have started outsourcing the complex bio analysis to reduce costs and to take advantage of specialized expertise to improve efficiency in drug development process. For instance, in March 2018, the SenzaGen entered into a key license agreement with Burlesson Research Technologies, Inc., (BRT), a U.S.-based contract research organization, specializing in immunotoxicology.
This agreement will provide BRTs 'GARD' to a broader market, which is a group of tests for assessing chemical sensitizers, where the test uses genetic biomarkers for over 200 genes, which cover an entire immune reaction and are relevant to predicting the risk of hypersensitivity. Therefore, such advancement and innovation by market players is expected to drive growth of the global biomarkers market during the forecast period.
Increasing application and awareness about biomarker tests is expected propel the global biomarkers market during the forecast period. Biomarkers find applications in diagnostics and in early detection of typical diseases. Furthermore, biomarkers such as BRCA1 exhibits whether or not an individual has an increased likelihood of developing cancer. Biomarkers are also used in a wide variety of therapeutic areas, including neurological diseases, immune deregulation, metabolic disorders, and oncology to treat various disease such as TMI, cancer, Alzheimer diagnosis. Moreover, biomarkers find applications in detection of ABO haemolytic disease of newborn, Huntington disease, hereditary haemochromatosis, and cystic fibrosis.
Furthermore, biomarkers are used for detection chromosome structure-associated diseases such as, Turner syndrome, Down syndrome, patau syndrome, Edwards's syndrome, and others, which is expected to boost the demand for biomarkers in the near future
Key players are focused on various growth strategies such as product launches, in order to gain competitive edge in the market. For instance, in 2016, Abbott Laboratories launched Point-of-Care i-STAT Alinity, an innovative, handheld blood testing platform.
Get PDF Brochure of Research Report - https://www.coherentmarketinsights.com/insight/request-pdf/1530
Detailed Segmentation:
Global Biomarkers Market, By Product Type:
Biomarker Test Kits
Biomarker Analyzers
Global Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
Global Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
Global Biomarkers Market, By End User:
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
Major companies operating in the global biomarkers market are Medtronic plc, BG Medicine, Inc., F. Hoffmann-La Roche Ltd., Seimens Healthnineers, Nexus-DX, Qiagen N.V., and Lifesign LLC.
Get More About Biomarkers Market @ https://www.coherentmarketinsights.com/market-insight/biomarkers-market-1530
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Biomarkers Market Future Challenges and Analysis, 2018-2026